Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations

Plastic and Reconstructive Surgery

Volumn 129, Issue 6, 2012, Pages

  Kulungowski, Ann M ^a,b,c   Hassanein, Aladdin H ^a,b,c   Nosé, Vĝnia ^a,b,c   Fishman, Steven J ^a,b,c   Mulliken, John B ^a,b,c   Upton, Joseph ^a,b,c   Zurakowski, David ^a,b,c   Divasta, Amy D ^a,b,c   Greene, Arin K ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER; ESTROGEN RECEPTOR; GROWTH HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADOLESCENT; ADULT; ARTERIOVENOUS MALFORMATION; ARTICLE; BIOSYNTHESIS; BLOOD VESSEL; CHILD; COMPARATIVE STUDY; CONGENITAL BLOOD VESSEL MALFORMATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LYMPH VESSEL; LYMPHATIC SYSTEM DISEASE; MALE; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; ARTERIOVENOUS MALFORMATIONS; BIOLOGICAL MARKERS; BLOOD VESSELS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LYMPHATIC ABNORMALITIES; LYMPHATIC VESSELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, SOMATOTROPIN; VASCULAR MALFORMATIONS; YOUNG ADULT;

EID: 84861722447     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31824ec3fb     Document Type: Article

References (39)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412-422.
2. Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: Natural history and management. Plast Reconstr Surg. 1998;102:643-654.
3. Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM. 25 years' experience with lymphangiomas in children. J Pediatr Surg. 1999;34:1164-1168.
4. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: Complications and results. Plast Reconstr Surg. 1999;104:1-11; discussion 12-15.
5. Liu A, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: Natural progression and recurrence after treatment. Plast Reconstr Surg. 2010; 125:1185-1194.
6. Fliegelman LJ, Friedland D, Brandwein M, Rothschild M. Lymphatic malformation: Predictive factors for recurrence. Otolaryngol Head Neck Surg. 2000;123:706-710.
7. Upton J, Coombs CJ, Mulliken JB, Burrows PE, Pap S. Vascular malformations of the upper limb: A review of 270 patients. J Hand Surg Am. 1999;24:1019-1035.
8. Huikeshoven M, Koster PH, de Borgie CA, Beek JF, van Gemert MJ, van der Horst CM. Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med. 2007;356:1235-1240.
9. Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK. Venous malformation: Risk of progression during childhood and adolescence. Ann Plast Surg. 2012;68:198-201.
10. Hassanein AH, Mulliken JB, Fishman SJ, Quatrano NA, Zurakowski D, Greene AK. Lymphatic malformation: Risk of progression during childhood and adolescence. J Craniofac Surg. 2012;23:149-152.
11. Lu L, Bischoff J, Mulliken JB, Bielenberg DR, Fishman SJ, Greene AK. Increased endothelial progenitor cells and vasculogenic factors in higher-staged arteriovenous malformations. Plast Reconstr Surg. 2011;128:260e-269e. 12. Joseph IB, Nelson JB, Denmeade SR, Isaacs JT. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res. 1997;3: 2507-2511.
12. Häggström S, Lissbrant IF, Bergh A, Damber JE. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J Urol. 1999;161:1620-1625.
13. Stewart RJ, Panigrahy D, Flynn E, Folkman J. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: Evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. J Urol. 2001;165:688-693.
14. Lissbrant IF, Lissbrant E, Persson A, Damber J, Bergh A. Endothelial cell proliferation in male reproductive organs of adult rat is high and regulated by testicular factors. Biol Reprod. 2003;68:1107-1111.
15. Lissbrant IF, Hammarsten P, Lissbrant E, Ferrara N, Rudolfsson SH, Bergh A. Neutralizing VEGF bioactivity with a soluble chimeric VEGF-receptor protein flt(1-3)IgG inhibits testosterone-stimulated prostate growth in castrated mice. Prostate 2004;58:57-65.
16. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res. 2000;60:3183-3190.
17. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci USA. 2000;97:10972-10977.
18. Nayak NR, Brenner RM. Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J Clin Endocrinol Metab. 2002;87:1845-1855.
19. Kayisli UA, Luk J, Guzeloglu-Kayisli O, Seval Y, Demir R, Arici A. Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroids. J Clin Endocrinol Metab. 2004;89:5794-5802.
20. Xiao X, Liu J, Sheng M. Synergistic effect of estrogen and VEGF on the proliferation of hemangioma vascular endothelial cells. J Pediatr Surg. 2004;39:1107-1110.
21. Johannisson E, Oberholzer M, Swahn ML, Bygdeman M. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception 1989;39:103-117.
22. Hyder SM, Huang JC, Nawaz Z, et al. Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect. 2000;108:785-790.
23. Heryanto B, Rogers PA. Regulation of endometrial endothelial cell proliferation by oestrogen and progesterone in the ovariectomized mouse. Reproduction 2002;123:107-113.
24. Gould J, Aramburo C, Capdevielle M, Scanes CG. Angiogenic activity of anterior pituitary tissue and growth hormone on the chick embryo chorio-allantoic membrane: A novel action of GH. Life Sci. 1995;56:587-594.
25. Struman I, Bentzien F, Lee H, et al. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA. 1999;96:1246-1251.
26. Thorey IS, Hinz B, Hoeflich A, et al. Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis, and myofibroblast differentiation. J Biol Chem. 2004; 279:26674-26684.
27. Lincoln DT, Singal PK, Al-Banaw A. Growth hormone in vascular pathology: Neovascularization and expression of receptors is associated with cellular proliferation. Anticancer Res. 2007;27:4201-4218.
28. Banziger-Tobler NE, Halin C, Kajiya K, Detmar M. Growth hormone promotes lymphangiogenesis. Am J Pathol. 2008; 173:586-597.
29. Katz MH. Interpreting the results. In:Multivariable Analysis: A Practical Guide for Clinicians and Public Health Researchers 3rd ed. New York: Cambridge University Press; 2011:140-161.
30. Styne DM. The regulation of pubertal growth. Horm Res. 2003;60:22-26.
31. Veldhuis JD, Roemmich JN, Richmond EJ, et al. Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev. 2005;26:114-146.
32. Folkman J. Anti-angiogenesis: New concept for therapy of solid tumors. Ann Surg. 1972;175:409-416.
33. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 1994;79:315-328.
34. Folkman J. Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence. Endocrinology 1998;139: 441-442.
35. Folkman J. Angiogenesis-dependent diseases. Semin Oncol. 2001;28:536-542.
36. Rupnick MA, Panigrahy D, Zhang CY, et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA. 2002;99:10730-10735.
37. Greene AK, Wiener S, Puder M, et al. Endothelial directed hepatic regeneration after partial hepatectomy. Ann Surg. 2003;237:530-535.
38. Kleinman ME, Greives MR, Churgin SS, et al. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol. 2007;27:2664-2670.
39. Duyka LJ, Fan CY, Coviello-Malle JM, Buckmiller L, Suen JY. Progesterone receptors identified in vascular malformations of the head and neck. Otolaryngol Head Neck Surg. 2009;141: 491-495.